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ABSTRACT 
 
Immunosenescence and alterations in the intestinal microbiota are associated with aging. 
Immune functions, as well as the intestinal microbiota, can potentially be modified and 
improved by probiotics, thus being particularly beneficial to elderly consumers. The ability 
of Lactobacillus paracasei Lpc-37 to modulate immune markers including phagocytic 
activity, natural killer (NK) cell activity and cytokine profiles, as well as composition and 
activity of the intestinal microbiota, in healthy elderly subjects was investigated in a 
randomised, double-blind, placebo-controlled study.  
Only very limited effects in the measured blood or faecal immune markers or intestinal 
microbiota could be detected between the fermented milk drinks with or without probiotics. 
Thus, no significant immunological or microbial effects of the probiotic fermented milk could 
be detected in this study population. 
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1. INTRODUCTION 
 
During the past century, life expectancy increased by almost 30 years, elderly being the 
most rapidly expanding sector of the population. In fact, in most developed countries life-
expectancy for those born during the last decade is expected to exceed 100 years 
(Christensen et al., 2009). This represents a challenge for modern societies and new 
approaches to improve health and reduce disease-risk among elderly are needed.  
 
Aging has been related with changes in immune function (Mazari and Lesourd 1998) and gut 
microbiota composition (Claesson et al., 2011). These age-related changes represent 
targets for the development of nutritional intervention strategies specifically directed to the 
elder population. Among these strategies, the development of functional foods including 
probiotics constitutes a promising approach. Whilst in healthy adults the immune system is in 
balance and will unlikely be affected by probiotics, elderly represent a group with a 
’challenged’ immune system. 
 
Elderly are more prone to infections and gastrointestinal problems (Bhutto and Morley 2008). 
In fact, an altered immune response has been described in elderly, a phenomenon known as 
immune-senescence (Candore et al., 2008). In elderly, these changes often include a 
reduced natural killer (NK) cell activity (Mocchegiani et al., 2009). Cytotoxic activity of NK 
cells plays a role on the response against viruses and cancer cells (Kazue et al., 2000) and 
therefore a reduced NK activity may, at least partially, explain the higher incidence of 
infections in elderly subjects. The intestinal microbiota has an important role in the health 
and well being of humans of all ages, but it is also important during old age; among others in 
modulating immune function. The intestinal microbiota composition in elderly is different from 
that of younger adults, showing reduced levels of potentially beneficial microorganisms and 
higher numbers of harmful bacteria in their intestines (Hayashi et al., 2003; Woodmansey 
2007; Hopkins et al., 2001, 2002). This change is likely due to factors that are related to 
ageing, like reduced mobility and suboptimal nutrition.  
 
It has been shown that the immune system of different population groups (i.e. healthy vs 
atopic adults) may react differently to probiotics (Roessler et al., 2008) and, therefore, 
probiotic containing products targeting elderly should be tested in this specific population. 
Different probiotic strains have been studied in the elderly population and some strains have 
been found to show immunomodulatory properties (Gill et al., 2001; Ouwehand et al., 2008; 
Ibrahim et al., 2010; Takeda and Okumura 2007; Sheih et al., 2001) or to reduce the 
duration of infections (Guillemard et al., 2010).  
 
The objective with this study was to determine the properties of a milk drink containing 
Lactobacillus paracasei Lpc-37 on immune function and intestinal microbiota in healthy 
elderly subjects. This strain has been shown to pose immunomodulatory properties in 
healthy adults (Paineau et al., 2008), and suggested to be able to alter the activity of 
intestinal microbiota (Valerio et al., 2010). Additionally, the Lpc-37 strain has been reported 
to modulate the immune system in adults (Roessler et al., 2008). Thus, we studied whether 
L. paracasei Lpc-37 is able to modulate immune markers including phagocytic activity, NK 
cell activity, cytokine profiles or faecal IgA, as well as the influence of the product on 
composition and activity of the intestinal microbiota, on elderly subjects. 
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2. SUBJECTS AND METHODS 
 
2.1 Volunteers and Study Design 
 
Faecal and blood samples were obtained from 40 elderly (67 to 95 years, mean 82.3 years) 
volunteers recruited from 3 nursing elderly homes in Gijon city area (Asturias, Spain). 
Exclusion criteria for the subjects were: consumption of antibiotics in the past month, lactose 
intolerance, regular consumption of probiotics/prebiotics, history of colon cancer, 
inflammatory bowel diseases or intestinal surgery.  
 
The double-blind, placebo controlled, parallel study design consisted in three phases. A 4 
weeks run-in phase, a 4 weeks intervention phase in which the volunteers were randomly 
allocated to the placebo or test groups and a 3 weeks wash-out period. Randomization was 
achieved by using GraphPad program (www.graphpad.com/quickcalcs/index.cfm) by using 
random numbers to assign subjects to treatment groups within each elderly home. During 
the run-in period volunteers were asked not to consume probiotic/prebiotic products or 
yogurt. During the intervention phase the subjects consumed daily one bottle of placebo 
(100 ml of fermented milk drink) or Lpc-37 product (the same product containing 3 x 109 
CFU L. paracasei Lpc-37, ATCC SD 5275, (Danisco, Niebüll, Germany). Both the fermented 
placebo milk drink and the fermented probiotic milk drink were manufactured by Senoble 
(Jouy, France) using proprietary starter strains. During the whole duration of the study 
volunteers continued consuming their habitual diet. 
 
The number of subjects in the study is based on previous studies (Sheih et al., 2001) in 
which the same parameters were determined. To detect differences of 20% between 
placebo and test products, on NK or phagocytic activity, at a significance level of 0.05 with 
an 80% power, a total of 34 volunteers would be needed. Thus, we recruited 40 allowing for 
some drop-outs. The study was approved by the Regional Ethical Committee on Clinical 
Research from the Asturias Principality (Asturias, Spain). All volunteers, as well as a close 
relative, gave written informed consent to participate in the study. 
 
Faecal and blood samples were collected from the volunteers at the end of each study 
phase. Faecal samples were immediately frozen at -80 °C and stored until further analysis. 
Heparinized peripheral blood was drawn for assessment of immune parameters and blood 
serum was immediately frozen at -80ºC and stored until further cytokine analyses. At the 
different sampling points the volunteers also answered a Diet and Quality of Life- 
questionnaire. 
 
2.2 Diet and Quality of Life Questionnaire 
 
Dietary intake was assessed by determination of the average frequency of each food offered 
by the institution, after they had provided us with the menus, so that estimation of 
consumption does not depend upon participant´s memory. The menus served on the 
different elderly homes were nutritionally assessed and on the basis of these menus a food 
frequency questionnaire was specifically designed for each nursing home by an experienced 
nutritionist. The dietitian asked each kitchen chef about cooking practices and number and 
amount of ingredients used in each recipe, as well as questions concerning menu 
preparation (such as type of oil used, type of milk, etc.). During interviews, subjects were 
asked item-by-item whether they usually ate each food and, if so, how much of it did they 
ate. 
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At the different sampling points the questionnaire including the food consumption, as well as 
questions related to habits and quality of life introduced in the questionnaire by trained 
nutritionists, was filled in by means of a personal interview. These questions related to 
sleeping habits (hour of dream, having siesta, awakens during night, perception of rest), 
bowel function (depositions per week, consistency of faeces, use of laxatives, pain during 
defecation), mood (happiness self-perception, depression) and diet (appetite, ration size, 
chewing problems). When appropriate the volunteers were asked to rank the responses on 
a scale from 0 to 4. In the same interview an anthropometry was carried out. 
 
Nutrient intake was calculated by using the Nutrient Composition tables CSIC 1994 and 
Wander Sandoz Nutrition 1990. 
 
2.3 Immune Measurements 
 
Heparinized whole blood was used to determine phagocytic activity. To this end 
phagocytosis of fluorescein (FITC) labelled E. coli cells was determined by using the 
Phagotest® kit (Orpegen Pharma, Heildelberg, Germany), according to the manufacturer’s 
instructions, by using a FACSCanto II flow cytometer (Becton Dickinson, BD Biosciences, 
San Diego, CA). 
 
Human peripheral blood mononuclear cells (PBMCs) from each volunteer were obtained 
from heparinized blood by centrifugation over a Ficoll-Hypaque gradient (Lymphoprep, 
Nycomed, Oslo, Norway). Cells were counted by trypan blue exclusion test and adjusted to 
5 x 106 cells/mL. Then, NK cell activity was determined by specific target lysis of labelled 
K562 cells by flow cytometry, using a commercially available kit (NKtest®, Orpegen Pharma) 
following the manufacturer’s instructions. 
 
The levels of IL-10, TNF-α, IL-8, IL-17, and IL-12p70 in blood sera were quantified by a 
multiplex immunoassay (Cytometric Bead Array, CBA, BD Biosciences) using a FACSCanto 
II flow cytometer. The concentrations of TGF-β were measured using an ELISA kit (BD 
OptEIATM, BD Biosciences). C-reactive protein (CRP) levels in plasma were determined by 
using the Human CRP Instant ELISA (Bender Medsystems, Vienna, Austria) kit according to 
the manufacturer’s instructions and results were expressed as ng/mL. Faecal concentrations 
of IgA, calprotectin and prostaglandin E2 (PGE2) were determined by using Human IgA 
ELISA Quantitation Kit E80-102 (Bethyl Laboratories Inc., Montgomery, TX, USA), Phical 
ELISA test (Calpro AS, Oslo, Norway), and PGE2 EIA Kit (Cayman Chemical Company, MI, 
USA) according to the manufacturers’ instructions. The results were expressed as µg/g of 
faeces (fresh weight) for IgA and calprotectin, and pg/g for PGE2. 
 
2.4 Microbiological Analyses 
 
One g of faecal sample was used for DNA extraction by using the QIAamp DNA stool mini 
kit (Qiagen, Hilden, Germany) as previously described (Gueimonde et al., 2004). 
Quantification of the different bacterial populations in faeces was performed by quantitative 
PCR in 25 µL PCR reactions by using primers and conditions shown in Table 1.   
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Table 1: Oligonucleotides and conditions used for the bacterial qPCR assays 
 
Target Primer Conc. 
(nM) 
AnnealingTm Reference 
Akkermansia spp. F:CAGCACGTGAAGGTGGGGAC 200 60 Collado et 
al. 2007 R:CCTTGCGGTTGGCTTCAGAT 
Bacteroides–Prevotella – Porphyromonas 
F:GAGAGGAAGGTCCCCCAC 
200 60 
Layton et 
al., 2006 
R:GCKACTTGGCTGGTTCAG 
Ramirez-
Farias et 
al., 2009 
Bifidobacterium spp. F:ATTCTGGCTCAGGATGAACGC 200 60 Gueimonde 
et al. 2004 R:CTGATAGGACGCGACCCCAT 
Clostridia XIVa 
Blautia coccoides–  
Eubacterium rectale 
F: CGGTACCTGACTAAGAAGC 
200 55 Rinttilä et 
al., 2004 R: AGTTTYATTCTTGCGAACG 
Clostridia IV        
Clostridium leptum–  
Faecalibacterium prausnitzii 
F: TTAACACAATAAGTWATCCACCTGG 
200 60 
Ramirez-
Farias et 
al., 2009 R: ACCTTCCTCCGTTTTGTCAAC 
Clostridium difficile 
F:TGAGCGATTTACTTCGGTAA 
150 60 Lahtinen et 
al. 2011 R:CCATCCTGTACTGGCTCACCT 
C. difficile TcdA 
F: TCTACCACTGAAGCATTACAGCTACAG 300 60 This study R: TGTAGGTACTGTAGGTTTATTGATTTGAGAT 
P: GGATTTTGAATCTCTTCCTCTAGTAGCGCGTG 200 
Enterobacteriaceae F:TGCCGTAACTTCGGGAGAAGGCA 200 58 Matsuda et 
al., 2007 R:TCAAGGACCAGTGTTCAGTGTC 
Lactobacillus group 
F: AGCAGTAGGGAATCTTCCA 
200 60 
Peso 
Echarri et 
al. 2011 R: CATGGAGTTCCACTGTCCTC 
Lactobacillus paracasei 
F:ACATCAGTGTATTGCTTGTCAGTGAATAC 300 60 Haarman & Knol 2006 R:CCTGCGGGTACTGAGATGTTTC P:TGCCGCCGGCCAG 200 
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Standard curves were made with pure cultures of appropriate strains (Akkermansia 
muciniphila CIP107961, Bacteriodes thetaiotaomicron DSMZ2079, Bifidobacterium longum 
NCIMB8809, Blautia coccoides DSMZ935, Clostridium leptum DSMZ753, Clostridium 
difficile ATCC 1382, Escherichia coli ATCC 11775,  Lactobacillus gasseri IPLAIF7/5 and L. 
paracasei Lpc-37) which were grown overnight in GAM medium (Nissui Pharmaceutical Co, 
Tokio, Japan) under anaerobic conditions. The Akkermansia, Bacteroides, Bifidobacterium, 
Bl. coccoides-E. rectale group, C. leptum group, C. difficile, and Lactobacillus qPCR assays 
were performed with a 7500 Fast Real Time PCR System (Applied Biosystems, Foster City, 
CA, USA) using SYBR Green PCR Master Mix (Applied Biosystems). For C. difficile TcdA 
and L. paracasei a TaqMan qPCR assay was used (TaqMan Master mix, Applied 
Biosystems). Faecal DNA extracts were analyzed and the mean quantity per g faecal wet 
weight was calculated.  
 
The total bacterial load was determined by using a flow cytometric FACSCalibur-system (BD 
Biosciences) as previously described (Apajalahti et al., 2002). For determination, the 
samples were fixed with formaldehyde (final concentration 4%) and stained with a 
fluorescent, nucleic acid binding dye, SYTO 24 (Molecular Probes, Leiden, the Netherlands). 
 
2.5 Chemical Analyses 
 
Analysis of short chain fatty acids (SCFAs) was performed using gas chromatography 
essentially as described before (Salazar et al., 2011), analyzing the concentration of 
acetate, propionate, isobutyrate, butyrate, isovalerate, and valerate. Concentrations of 
biogenic amines (methylamine, putrescine, piperidine, cadaverine, histamine, tyramine, 
spermidine, and spermine) were determined as dansyl derivatives by reversed phase HPLC 
as previously reported by Saarinen (Saarinen 2002). 
 
2.6 Statistical Analysis 
 
The data from the study was analyzed with linear mixed effects models in a repeated 
measures fashion, using a random effect for the subject accounting for repeated measures. 
The models had fixed effects for time point, treatment, gender, nursing home, and an 
interaction term for combination of time point and treatment. Continuous valued variables 
body mass index and age were also included in the models as covariates. In addition, there 
was a baseline regression coefficient accounting for individual baseline differences between 
the subjects. Based on the residual analysis, some of the original variables were log-
transformed. The linear model analyses were conducted with statistical programming 
language R (version 2.11.1) using nlme package (version 3.1-97). Wilcoxon test was used 
for before-after comparisons within each treatment group. The obtained P-values were 
considered as statistically significant at P < 0.05. 
 
3. RESULTS  
 
3.1 Diet and Quality of Life 
 
Differences in background data (gender ratio, age, weight, use of anticoagulant and 
antihypertensive drugs, etc.) were not observed between the placebo and probiotic groups 
(data not shown). With regard to drop-outs only 1 person (placebo group) dropped out for 
claiming self-reported lack of tolerance (but when asked for specific symptoms was not able 
to describe them) and one was moved from the elderly home. In this group there were also 
two volunteers that dropped-out before the end of the study because they were hospitalized 
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because a respiratory infection and breaking a hip (these last two subjects were excluded 
and not considered for the study). In the probiotic group, one volunteer was moved to 
another elderly home and another one went on holidays with her family before the end of the 
study, and thus, some samples were not available.  
 
Intake of nutrients did not differ between the groups neither at baseline nor at the end of 
intervention or during washout. At baseline energy intakes were 1810 ± 380 and 1740 ± 390 
(kcal/day, mean ± SD) for placebo and intervention groups, respectively, 1899 ± 321 and 
1824 ± 287 at the end of intervention, and 1869 ± 242 and 1678 ± 341 at the end of the 
washout period. With regard to macronutrients, intake of proteins ranged between 72 and 81 
g/d, those of lipids between 73 and 85 g/d and those of carbohydrates ranged between 170 
and 218 g/d, without differences between placebo and probiotic groups. No differences were 
found for intake of fiber (14-19 g/d), cholesterol (222-286 mg/d) or fatty acids (28-42, 25-30 
and 13-16 g/d for saturated, monounsaturated and polyunsaturated fatty acids respectively) 
or for micronutrients. Statistical analysis of the QoL questionnaires did not show any 
significant differences in the parameters included (sleeping habit, bowel function, mood or 
appetite) (data not shown). 
 
3.2 Immune Variables 
 
Both the placebo and probiotic milk drinks increased significantly (P = 0.020 and P = 0.048, 
respectively) the NK activity at the end of the intervention (34.1 ± 12.8% and 27.4 ± 13.0% 
for placebo and probiotic group, respectively) when compared with those at baseline (25.2 ± 
8.2% and 22.1 ± 5.9%). However, between-group analyses did not show any statistically 
significant difference on NK activity. The percentages of phagocytic cells ranged between 89 
and 93% in the different groups and time points without showing any statistically significant 
difference. However, when the phagocytic activity per cell was determined, by measuring 
the mean fluorescent intensity per cell, whilst statistically significant differences were not 
observed at baseline (placebo: 12686 ± 8050 vs probiotic: 13210 ± 8654), a significantly (P 
= 0.0137) lower activity was observed in the probiotic group at the end of the intervention 
(placebo 16946 ± 7820 vs. probiotic: 14162 ± 7751). 
 
At the end of intervention, despite the slightly higher values of total faecal IgA (164 ± 174 vs. 
106 ± 86 µg/g wet weight faeces), PGE2 (1297 ± 498 vs. 834 ± 295 pg/g wet weight faeces) 
and calprotectin (124 ± 95 vs. 112 ± 82 pg/g wet weight faeces) observed in the probiotic 
group than in the placebo group, the differences did not reach statistical significance at any 
analyzed time point (Figure 1). Cytokines levels showed a large inter-individual variability 
and, as well as CRP, did not show any statistically significant differences between groups or 
time points (data not shown). 
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Figure 1: Faecal immune markers IgA, PGE2 and calprotectin in  
placebo and probiotic groups.  
Values are presented as means + SD. 
 
3.3 Faecal Microbiota 
 
Consumption of placebo milk drink or milk drink supplemented with L. paracasei Lpc-37 for 4 
weeks resulted in only minor changes in the gut microbiota composition (Figure 2). Despite 
the high inter-individual variability, a trend (nonsignificant, P = 0.0626) towards higher levels 
of lactobacilli and a significantly higher number (P = 0.0012) of L. paracasei was detected in 
the probiotic group, than in placebo, at the end of the intervention. No other statistically 
significant effects on the gut microbiota composition were observed.  
 
3.4 SCFA and Biogenic Amines Concentrations 
 
The probiotic group had a slightly higher, although nonsignificant, total faecal SCFA 
concentration than the placebo group at the end of intervention. Acetic acid was the major 
SCFA in both groups, and a small increase of acetate could be detected for both groups 
during the intervention, contributing from 42% at baseline to 50% of total SCFA after the 
intervention (Figure 3). In general, the levels remained mainly unchanged and no statistically 
significant differences were observed. A high inter-individual variability was observed on 
both the faecal SCFA concentration as well as for the biogenic amines. No significant 
differences for the biogenic amines occurred between the probiotic and the placebo group 
(Figure 4), cadaverine being the predominant polyamine in both groups. 
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Figure 2: Levels (Log10 microorganisms/g of faecal wet weight) of the different microbial groups analyzed (mean + SD).  
Asterisk (*) indicates statistically significant differences between placebo (pla) and probiotic (pro) groups. 
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Figure 3: SCFA profiles (µg/g of faeces) determined by GC investigating the effects of 
the probiotic milk drink in comparison to the placebo (mean + SD). 
 
 
 
Figure 4: Biogenic amine profiles (nmol/g faeces) of the healthy elderly (mean + SD). 
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4. DISCUSSION 
 
In this study, L. paracasei Lpc-37 was used since previous reports have suggested that L. 
paracasei strains are able to alter the activity of intestinal microbiota (Valerio et al., 2010). 
Additionally, the Lpc-37 strain has been reported to modulate the immune system in adults 
(Roessler et al., 2008). However, in this study, with the sole exception of a lower phagocytic 
activity per cell, no significant effects of the probiotic fermented milk drink were detected on 
the measured immune functions. These results indicate a very limited effect on the immune 
system of the probiotic product, when compared to the placebo fermented milk, this maybe, 
at least partly, due to the use of a fermented milk drink as placebo, as pointed out by the 
increase in NK activity after the intervention phase observed not only for the probiotic 
product but also for the placebo. This fact, underlines the difficulties on obtaining a “neutral” 
placebo product when conducting studies with fermented products containing life bacteria. In 
addition, the dose used here (109 CFU/day) was lower than that used by Paineau and 
coworkers (Paineau et al., 2008) in healthy adults (2 x 1010) and, whilst we used the strain 
together with the yogurt starter, Roessler and co-workers (Roessler et al., 2008) used it in 
combination with two other probiotic strains. Therefore the comparison of their results with 
those obtained in the present study is limited. 
 
Quite large inter-individual variations were detected for the measured faecal immune 
markers IgA, calprotectin and PGE2, within both groups. The faecal IgA and calprotectin 
levels were comparable to previous studies of healthy elderly and adults (Tiihonen et al., 
2008; Ouwehand et al., 2008; Maiden et al., 2005). The faecal PGE2 levels found were 
higher, already from the beginning, than those reported for elderly in another study 
(Ouwehand et al., 2008). In addition to immune modulation, PGE2 has a central role in the 
normal physiological gastrointestinal functions including cytoprotection. In the present study, 
the faecal concentrations of PGE2 were similar to what has been reported to healthy young 
adults (Tiihonen et al., 2008). Thus, this suggests that in the present study the mucosal 
protection in the stomach and duodenum is not decreased in the target population, in 
contrast to other studies (Tiihonen et al., 2008; Newton 2005). 
 
No large differences between the placebo and the probiotic groups could be detected for the 
bacterial species or groups analysed, the levels being similar to those previously reported by 
other authors (Candela et al., 2010; Collado et al., 2007). As expected, the probiotic milk 
drink was found to significantly increase the faecal numbers of the administered 
microorganism, L. paracasei. C. difficile is a natural resident of the intestinal microbiota in 
infants (Jangi and Lamont 2010) and adults (Ozaki et al., 2004), but it may become harmful 
when overrepresented in the intestinal microbiota. Most individuals with C. difficile 
symptoms are elderly (>60 years) (Simor et al., 2002), however the detected levels of C. 
difficile in the present study were very low and none of the samples tested positive for C. 
difficile toxin. 
 
Regarding the metabolic activity of the intestinal microbiota, and as expected from the lack 
of major effects on gut microbiota composition, only minor changes in the levels of SCFA 
were observed and these did not differ between the treatment groups. A slight increase in 
the total amount of SCFA could be detected in both the probiotic and the placebo group. 
However, since the majority of generated SCFA in the colon are absorbed during transit of 
digesta through the gut (Topping and Clifton 2001), large differences can be hard to detect. 
Biogenic amines play an important role in metabolic and physiological functions and in this 
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study no significant difference between the groups could be detected for the biogenic 
amines. 
 
5. CONCLUSIONS 
 
In this study, only very limited effects on the measured immune markers or intestinal 
microbiota of healthy elderly were detected for the Lpc-37-containing fermented milk when 
compared with the placebo fermented milk. The recruited elderly were among the healthiest 
in their age class, which may explain the limited response observed in this study. However, 
the results indicate that this bacterial strain will not have a significant impact on immune 
function or gut microbiota in this population.  
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